[Skip to Content]
[Skip to Content Landing]
October 1987

Topically Applied Aminocaproic Acid Concentrates in the Aqueous Humor of the Rabbit in Therapeutic Levels

Author Affiliations

From the Departments of Ophthalmology (Drs Allingham, Crouch, and Loewy and Mr Demkowski) and Pharmacology (Dr Williams), Eastern Virginia Medical School, Norfolk.

Arch Ophthalmol. 1987;105(10):1421-1423. doi:10.1001/archopht.1987.01060100123041

• Systemically administered aminocaproic acid, used to reduce the incidence of secondary hemorrhage in traumatic hyphema, has been shown to accumulate in the aqueous humor of rabbits in a dose-dependent manner. Eight topical preparations of aminocaproic acid were studied to determine aqueous humor concentrations. The vehicles studied included the following: sodium chloride, 0.85 g/dL; polyvinyl alcohol, 1.4 g/dL; hydroxypropyl methylcellulose, 0.4 g/dL; benzalkonium chloride, 0.01 g/dL; ethylenediamine tetraacetic acid disodium, 0.01 g/dL; dimethyl sulfoxide, 11 and 39.6 g/dL; and carboxypolymethylene, 4 g/dL. All contained 735 g/L of aminocaproic acid except for dimethyl sulfoxide (39.6 g/dL) and carboxypolymethylene (4 g/dL), which contained 238 and 600 g/L of aminocaproic acid, respectively. Aqueous humor and plasma samples were assayed for aminocaproic acid content following topical administration. Aqueous humor concentrations of aminocaproic acid ranged from undetectable (<0.01 mg/dL) to 5.75 mg/dL. Plasma concentrations ranged from undetectable (<0.01 mg/dL) to 9.85 mg/dL. Polyvinyl alcohol (1.4 g/dL) and carboxy polymethylene (4 g/dL) provided the highest aqueous humor aminocaproic acid concentrations. The aqueous humor levels with topical aminocaproic acid administration were comparable with those achieved by systemic administration. Plasma drug levels with topical aminocaproic acid were between 5% and 33% of levels achieved by systemic aminocaproic acid. This study demonstrates that aminocaproic acid can be effectively delivered into the anterior chamber of rabbits by topical application.

Edwards WC, Layden WE:  Traumatic hyphema: A report of 184 consecutive cases . Am J Ophthalmol 1973;75:110-116.
Thomas MA, Parrish RK II, Fever WJ:  Rebleeding after traumatic hyphema . Arch Ophthalmol 1986;104:206-210.Article
Read J, Goldberg MF:  Traumatic hyphema: Comparison of medical treatment . Ophthalmology 1974;78:788-815.
Crouch ER, Frenkel M:  Aminocaproic acid in the treatment of traumatic hyphema . Am J Ophthalmol 1976;81:355-360.
Read J, Crouch ER:  Trauma: Ruptures and bleeding , in Duane TD (ed): Clinical Ophthalmology . New York, Harper and Row Publishers Inc, 1983, vol 4, pp 1-17.
Palmer DJ, Goldberg MF, Frenkel M, et al:  A comparison of two dose regimens of epsilon aminocaproic acid in the prevention and management of secondary traumatic hyphema . Ophthalmology 1986;93:102-108.Article
Loewy DM, Williams PB, Crouch ER, et al:  Systemic aminocaproic acid increases antifibrinolysis in the aqueous humor of rabbits . Arch Ophthalmol 1987;105:272-276.Article
Farid NA:  Fluorescamine use in high performance liquid chromatographic determination of aminocaproic acid in serum . J Pharm Sci 1979;68:249-252.Article
Maurice DM:  Factors influencing the penetration of topically applied drugs . Int Ophthalmol Clin 1980;20:21-32.Article
Hardberger R, Hanna C, Boyd CM:  Effects of drug vehicles on ocular contact time . Arch Ophthalmol 1975;93:42-45.Article
Grass GM, Wood RW, Robinson JR:  Effects of calcium chelating agents on corneal permeability . Invest Ophthalmol Vis Sci 1985;26:110-113.
Jacob SW:  Pharmacology of DMSO , in Jacob SW, Rosenbaum EE, Wood DC (eds): Dimethyl Sulfoxide . New York, Marcel Dekker Inc, 1971, pp 100-104.
Norn MS, Oparroki A:  Effects of ophthalmic vehicle on the stability of the precorneal film . Acta Opthalmol 1977;55:23-33.Article
Schoenwalk RD, Ward RL, DeSantis LM, et al:  Influence of high-viscosity vehicles on miotic effect of pilocarpine . J Pharm Sci 1978;67:1280-1283.Article